Published in J Immunol on December 15, 1999
Transcriptional regulation by STAT6. Immunol Res (2011) 1.81
Transcriptional regulation of the NKT cell lineage. Curr Opin Immunol (2013) 1.75
The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction. Immunity (2007) 1.58
Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol (2002) 1.34
Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect Immun (2002) 1.19
Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet (2004) 1.19
An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3. J Exp Med (2001) 1.18
Thymic selection pathway regulates the effector function of CD4 T cells. J Exp Med (2007) 1.15
T helper subset development: roles of instruction, selection, and transcription. J Clin Invest (2002) 1.14
Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol (2010) 1.11
Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo. J Immunol (2008) 1.01
Osteopontin regulates development and function of invariant natural killer T cells. Proc Natl Acad Sci U S A (2008) 0.97
STAT6-dependent and -independent mechanisms in Th2 polarization. Eur J Immunol (2012) 0.95
Differential regulation of IL-4Ralpha expression by antigen versus cytokine stimulation characterizes Th2 progression in vivo. J Immunol (2009) 0.92
Immature murine NKT cells pass through a stage of developmentally programmed innate IL-4 secretion. J Leukoc Biol (2012) 0.86
Interleukin-4 receptor alpha chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas. Infect Immun (2002) 0.86
Induction and maintenance of IL-4 expression are regulated differently by the 3' enhancer in CD4 T cells. J Immunol (2011) 0.80
Elevated IL-6 expression in CD4 T cells via PKCtheta and NF-kappaB induces Th2 cytokine production. Mol Immunol (2009) 0.80
Role of IL-9 and STATs in hematological malignancies (Review). Oncol Lett (2013) 0.79
Plasma cell differentiation requires the transcription factor XBP-1. Nature (2001) 9.72
Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity (1996) 8.16
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature (1996) 6.23
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell (1993) 5.99
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14
Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science (1997) 3.92
Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med (2000) 3.84
The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity (1999) 3.61
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol (1998) 3.48
Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol (1999) 3.21
Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity (1996) 3.05
Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol (1995) 2.90
CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science (1999) 2.60
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 2.58
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med (1999) 2.42
The biology of Stat4 and Stat6. Oncogene (2000) 2.40
Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity (1994) 2.40
Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med (1998) 2.28
Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol (1998) 2.20
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest (2001) 2.19
The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity (1998) 2.13
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.86
Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature (1996) 1.82
Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity (1999) 1.69
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest (2000) 1.65
Expression of the CD4 gene requires a Myb transcription factor. Mol Cell Biol (1992) 1.62
Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.61
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med (1994) 1.61
Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc Natl Acad Sci U S A (1999) 1.60
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol (2001) 1.44
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest (2000) 1.44
Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol (1996) 1.43
A transcriptional silencer controls the developmental expression of the CD4 gene. EMBO J (1994) 1.42
Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J Exp Med (1993) 1.40
A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J Exp Med (1998) 1.36
Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol (1999) 1.34
Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways. J Immunol (2000) 1.33
Two levels of help for B cell alloantibody production. J Exp Med (1996) 1.31
Regulation of T helper cell differentiation by STAT molecules. J Leukoc Biol (1998) 1.30
A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties. Proc Natl Acad Sci U S A (1991) 1.28
STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J Immunol (1998) 1.27
Peripheral lymphoid development and function in TCR mutant mice. Int Immunol (1994) 1.26
B lymphocyte development and activation independent of MHC class II expression. J Immunol (1993) 1.25
Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med (1994) 1.24
Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J Immunol (2000) 1.22
Beneficial effects of targeting CCR5 in allograft recipients. Transplantation (2001) 1.22
Positive selection of CD4+ T cells by TCR ligation without aggregation even in the absence of MHC. Nature (1994) 1.21
The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest (2000) 1.19
Decreased neonatal dietary fat absorption and T cell cytotoxicity in pancreatic lipase-related protein 2-deficient mice. J Biol Chem (1998) 1.17
Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma. J Immunol (2000) 1.16
Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol (1998) 1.15
IL-12, STAT4-dependent up-regulation of CD4(+) T cell core 2 beta-1,6-n-acetylglucosaminyltransferase, an enzyme essential for biosynthesis of P-selectin ligands. J Immunol (2001) 1.13
Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. J Exp Med (1993) 1.11
A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice. Cell Immunol (1999) 1.10
Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell (1994) 1.10
Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J Immunol (1999) 1.09
Antigen-presenting function of B lymphocytes. Immunol Rev (1988) 1.06
Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J Exp Med (2001) 1.02
Thymocyte development in major histocompatibility complex-deficient mice: evidence for stochastic commitment to the CD4 and CD8 lineages. Proc Natl Acad Sci U S A (1993) 1.02
Most gamma delta T cells develop normally in the absence of MHC class II molecules. J Immunol (1993) 1.01
Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol (2000) 0.97
Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation. Proc Natl Acad Sci U S A (1984) 0.96
Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J Infect Dis (1995) 0.96
Activation of T cells by superantigen in class II-negative mice. J Immunol (1994) 0.95
Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc Natl Acad Sci U S A (1997) 0.92
Similarity between fluorescein-specific T-cell receptor and antibody in chemical details of antigen recognition. Proc Natl Acad Sci U S A (1992) 0.91
Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts. Oncogene (1999) 0.91
Transgenic mice expressing MHC class II molecules with truncated A beta cytoplasmic domains reveal signaling-independent defects in antigen presentation. Int Immunol (1995) 0.90
Immunoregulatory effects of superantigens: interactions of staphylococcal enterotoxins with host MHC and non-MHC products. Immunol Rev (1993) 0.89
STATs as mediators of cytokine-induced responses. Adv Immunol (1999) 0.88
Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy. J Reprod Immunol (1997) 0.86
Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes. Biochem Pharmacol (1993) 0.84
Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J Immunol (1997) 0.83
Upstream elements of the MHC class II E beta gene active in B cells. J Immunol (1991) 0.83
Marking IL-4-producing cells by knock-in of the IL-4 gene. Int Immunol (1999) 0.83
Genomic organization of the murine CTL lipase gene. Genomics (1996) 0.82
Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes. Proc Natl Acad Sci U S A (1996) 0.82
Positive selection of NKT cells by CD1(+), CD11c(+) non-lymphoid cells residing in the extrathymic organs. Eur J Immunol (1999) 0.82
CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts. Transplantation (1997) 0.82
Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. J Immunol (1999) 0.82
STAT6-deficient mice exhibit normal induction of murine AIDS and expression of immunoglobulin E following infection with LP-BM5 murine leukemia viruses. J Virol (1999) 0.81
In situ assays demonstrate that interferon-gamma suppresses infection-stimulated hepatic fibrin deposition by promoting fibrinolysis. J Thromb Haemost (2006) 0.80
Absence of T lymphocyte-derived cytokines fails to diminish macrophage 12/15-lipoxygenase expression in vivo. J Immunol (1998) 0.80
Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. J Immunol (1999) 0.80
IL-21 receptor signalling partially mediates Th2-mediated allergic airway responses. Clin Exp Allergy (2014) 0.79
Dual-receptor T cells expressing one self-restricted TCR. Scand J Immunol (1997) 0.78
Inhibition of bovine heart mitochondrial and Paracoccus denitrificans NADH----ubiquinone reductase by dequalinium chloride and three structurally related quinolinium compounds. Biochem Int (1989) 0.78
Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation. J Immunol (1997) 0.77
Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice. Transplantation (1995) 0.77
Cross-linking of protein S bound to lymphocytes promotes aggregation and inhibits proliferation. Cell Immunol (1997) 0.75
Induction of antigen-specific antibody responses by nonspecific T cell-derived helper factors. Immunol Res (1986) 0.75
Identification of an IL-4-inducible gene expressed in differentiating lymphocytes and male germ cells. Dev Immunol (1990) 0.75